SNRNP40

SNRNP40 is a subunit of the U5 small nuclear ribonucleoprotein (snRNP) complex of the spliceosome, where it acts alongside core U5 components including PRPF6, PRPF8, EFTUD2, and DDX23 to support accurate pre-mRNA splicing (PMID:31427773, PMID:33584830). Hypomorphic loss of function in mice produces widespread splicing errors, predominantly intron retention, across several hundred mRNAs in hematopoietic stem cells and T cells, altering expression of immune-associated proteins and causing a syndromic immune disorder with lymphoid developmental defects and viral hypersusceptibility (PMID:31427773). Engineered low expression of SNRNP40 in breast cancer cells enhances metastatic colonization, identifying it as a driver of metastatic fitness within variable subpopulations (PMID:27138336). Beyond its placement in the U5 snRNP and these phenotypic links to immune development and metastasis, the precise molecular contribution of SNRNP40 to spliceosome assembly or catalysis has not been characterized in the available corpus.

1. 2016 Medium

   Established that expression level of SNRNP40 functionally modulates cancer cell behavior, showing a spliceosomal gene can act as a determinant of metastatic colonization.

   Evidence Engineered variable/low expression in breast cancer cell lines with in vivo metastasis assays

   PMID:27138336

   Open questions at the time

   • No molecular mechanism linking SNRNP40 level to metastasis was established beyond its spliceosomal context
   • Specific splicing targets driving the phenotype not identified
   • Single-lab finding without orthogonal mechanistic follow-up
2. 2018 Low

   Tested whether SNRNP40 physically associates with transcriptional machinery, recovering it as a candidate nuclear interactor of KLF5.

   Evidence Co-immunoprecipitation of KLF5 followed by LC-MS/MS in TSU-Pr1 bladder cancer cells

   PMID:30289973

   Open questions at the time

   • Single Co-IP/MS without reciprocal validation; SNRNP40 was one of 122 candidates
   • Functional significance of the interaction not characterized
   • Cannot distinguish direct binding from co-complex or contaminant
3. 2019 High

   Defined the in vivo physiological consequence of SNRNP40 deficiency, demonstrating that the U5 snRNP subunit is required for splicing fidelity in hematopoietic and lymphoid cells and that its loss causes a syndromic immunodeficiency.

   Evidence Hypomorphic mouse genetic model with intron-retention quantification in primary HSCs and T cells plus cell-intrinsic rescue

   PMID:31427773

   Open questions at the time

   • Molecular role of SNRNP40 within U5 snRNP assembly or catalysis not resolved
   • Why intron retention predominates over other splicing error classes unexplained
   • Mechanism linking specific mis-spliced transcripts to immune phenotype not dissected
4. 2021 Medium

   Consolidated SNRNP40 within the U5 snRNP module and linked recurrent somatic mutations and altered expression to human cancers.

   Evidence Literature review synthesizing genetic variant and expression data across U5 snRNP components in disease cohorts

   PMID:33584830

   Open questions at the time

   • No new direct experiment; relies on synthesis of prior studies
   • Causal contribution of SNRNP40 mutations to cancer not experimentally tested
   • Functional distinction from other U5 components not addressed

• How SNRNP40 contributes mechanistically to U5 snRNP function and how its dosage produces opposite-direction phenotypes in immune cells versus metastatic cancer cells remains unresolved.
• No structural or biochemical definition of SNRNP40's role in spliceosome assembly
• Direct substrate/transcript determinants of phenotypes not mapped
• Reconciliation of immune-loss and cancer-fitness roles not established